Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

THEOLAIR-SR

THEOPHYLLINE

Standard Dose
500MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview THEOLAIR-SR is listed in Drugs@FDA under application 089132 (ANDA).

Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 500MG Sponsor 3M Submission history Latest submission status date: 1999-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview THEOLAIR-SR is listed in Drugs@FDA under application 089132 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 500MG Sponsor 3M Submission history Latest submission status date: 1999-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
THEOLAIR-SR (THEOPHYLLINE) | Drug Monograph | MedicHelpline